HIP / PAP POLYPEPTIDE COMPOSITION FOR USE IN HEPATIC REGENERATION AND FOR THE PREVENTION OF HEPATIC INSUFFICIENCY.

• 1. 用于肝再生和预防肝衰竭的HIP/PAP多肽组合物 [P] . 中国专利： CN1835764B . 2014.07.09
• 2. 用于肝再生和预防肝衰竭的HIP/PAP多肽组合物 [P] . 中国专利： CN1835764A . 2006-09-20
• 3. hip / pap polypeptide composition for use on leberregeneration and for the prevention of hepatic insufficiency [P] . 德国专利： DE602004029038D1 . 2010-10-21

  机译： 髋/ pap多肽组合物，用于白血病再生和预防肝功能不全

• 4. Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure [P] . 美国专利： US2006276388A1 . 2006-12-07

  机译： 用于肝脏再生和预防肝衰竭的髋/宫颈多肽组合物

• 5. HIP/PAP POLYPEPTIDE COMPOSITION FOR USE IN LIVER REGENERATION AND FOR THE PREVENTION OF LIVER FAILURE [P] . CA2529896C . 2014-02-11

  机译： 用于肝脏再生和预防肝功能衰竭的HIP / PAP多肽组合物

• 1. Evaluation and Risk Prevention and Control of Hepatic Injury by Traditional Drugs [J] . 肖小河 世界中西医结合杂志（英文） . 2019,第004期
• 2. Evaluation and Risk Prevention and Control of Hepatic Injury by Traditional Drugs [J] . Xiao Xiaohe 世界中西医结合杂志（英文） . 2019,第004期
• 3. Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP [J] . Shinji Yokoyama, Kuniko Okumura-Noji, Rui Lu 生物医学研究杂志（英文版） . 2015,第003期
• 4. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance [J] . Matsunaga Norikazu, Ufuk Ayse, Morse Bridget L., Drug Metabolism and Disposition: The Biological Fate of Chemicals . 2019,第3期
• 5. Phospholipid, cholesterol, polypeptide and glycoprotein composition of hepatic endosome subfractions [J] . W G Hardison, W H Evans The biochemical journal . 1985,第1期
• 6. Role of melatonin in the oxidative damage prevention at different times of hepatic regeneration [J] . GonzálezM.A., delCarmenContiniM., MillenN., Cell biochemistry and function . 2012,第8期
• 7. Flow and nitric oxide increase hepatic function in co-culturing hepatocytes with hepatic stellate cells and endothelial cells [C] . Sumii Tateki, Fujita Ryosuke, Tanishita Kazuo, 2011 International Symposium on Micro-NanoMechatronics and Human Science . 2011
• 8. Examining the regulation of hepatic drug disposition and metabolism by organic anion transporting polypeptide, P-glycoprotein and multidrug resistance-associated protein 2. [D] . Lau, Yvonne Yi-Yang. 2006
• 9. Phospholipid cholesterol polypeptide and glycoprotein composition of hepatic endosome subfractions. [O] . W H Evans, W G Hardison 1985
• 10. Hepatic Organic Anion Transporting Polypeptide–Mediated Clearance in the Beagle Dog: Assessing In Vitro–In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance [O] . Norikazu Matsunaga, Ayşe Ufuk, Bridget L. Morse, 2018

• 1. Effect of naked eukaryotic expression plasmid encoding rat augmenter of liver regeneration on acute hepatic injury and hepatic failure in rats [J] . Li-MeiZhang ,Dian-WuLiu ,Jian-BoLiu . 世界胃肠病学杂志：英文版 . 2005,第24期
• 2. Therapeutic effects of velvet antler polypeptides on hepatic fibrosis in rats [J] . Leng-xinDUAN ,Cai-eWANG ,Ji-leXIN . 中国药理学与毒理学杂志 . 2015,第S1期
• 3. 狭鳕鱼皮胶原多肽组合物水洗面膜的研制 [C] . 闫鸣艳 ,秦松 ,冯大伟 . 2011(第八届)中国日用化学工业论坛 . 2011
• 4. 多肽纳米软材料用于疾病标记物的检测 [A] . 秦韶佼 . 2020